Endocytosis‐independent and Cancer‐selective Cytosolic Protein Delivery via Reversible Tagging with LAT1 substrate
Ziyin Zhao,Xun Liu,Mengying Hou,Renxiang Zhou,Fan Wu,Jing Yan,Wei Li,Yujia Zheng,Qinmeng Zhong,Yongbing Chen,Lichen Yin
DOI: https://doi.org/10.1002/adma.202110560
IF: 29.4
2022-07-06
Advanced Materials
Abstract:Protein drugs targeting intracellular machineries have shown profound therapeutic potentials, but their clinical utilities are greatly hampered by the lack of efficient cytosolic delivery techniques. Existing strategies mainly rely on nanocarriers or conjugated cell penetrating peptides (CPPs), which often have drawbacks such as materials complexity/toxicity, lack of cell specificity, and endolysosomal entrapment. Herein, we report a unique carrier‐free approach for mediating cancer‐selective and endocytosis‐free cytosolic protein delivery. Proteins were sequentially modified with 4‐nitrophenyl 4‐(4,4,5,5‐tetramethyl‐1,3,2‐dioxaborolan‐2‐yl) benzyl carbonate as the H2O2‐responsive domain and 3,4‐dihydroxy‐L‐phenylalanine as the substrate of L‐type amino acid transporter 1 (LAT1). Thus, the pro‐protein could be directly transported into tumor cells by over‐expressed LAT1 on cell membranes, bypassing endocytosis and endolysosomal entrapment. In the cytosol, over‐produced H2O2 restored the protein structure and activity. Using this technique, versatile proteins were delivered into tumor cells with robust efficiency, including toxins, enzymes, CRISPR‐Cas9 ribonucleoprotein, and antibodies. Furthermore, intravenously injected pro‐protein of saporin showed potent anti‐cancer efficacy in 4T1 tumor‐bearing mice, without provoking systemic toxicity. Such a facile and versatile pro‐protein platform may benefit the development of protein pharmaceuticals. This article is protected by copyright. All rights reserved
materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology